Cecht FABN,[1] also called FABN Group,[2] is a German-French pharmaceutical conglomerate active in 2074. They develop new medicine for the URNC. Possibly for fiscal reasons, their former internal security group was spun off into a distinct company, the PMC Mangi Security Service. 85% of Mangi contracts involve transporting cargo for their former parent company.

FABN have been involved with Paradeus to produce Boojums[2] and are possibly linked to the Orlog Conglomerate.[2][3]

References edit